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Abstract
The aim of the present study has been to critically review 22 disease scoring systems (DSSs) on oral lichen planus 
(OLP) that have been reported in the literature during the past decades. Although the presently available DSSs 
may all have some merit, particularly for research purposes, the diversity of both the objective and subjective pa-
rameters used in these systems and the lack of acceptance of one of these systems for uniform use, there is a need 
for an international, authorized consensus meeting on this subject. Because of the natural course of OLP charac-
terized by remissions and exacerbations and also due to the varying distribution pattern and the varying clinical 
types, e.g. reticular and erosive, the relevance of a DSS based on morphologic parameters is somewhat question-
able. Instead, one may consider to only look for a quality of life scoring system adapted for use in OLP patients.
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Introduction
Lichen planus is a chronic autoimmune, inflammatory-
like mucocutaneous disease. The exact etiopathogen-
esis is still unknown. The disease occurs more often 
in females than in males with a ratio of approximately 
2:1 and mostly affects the middle-aged population. The 
reported prevalence of lichen planus in general is up to 
5%, while the prevalence of oral lichen planus (OLP)  is 
set at 1.2% (1). 
Cutaneous lichen planus (CLP) includes skin and nails. 
The lesions are distributed in a bilateral and more or 
less symmetrical pattern (2). Mucosal lichen planus 
(MLP) may involve the mouth, gastrointestinal tract, 
larynx, genitals, ears, nose, bladder and conjunctivae 
of the eyes. Oral lichen planus may occur isolated or in 
combination with involvement of cutaneous sites or oth-
er mucosal sites. In the past, six clinical types of OLP 
have been recognized, being reticular, papular, plaque-
like, atrophic, ulcerative/erosive, and bullous respec-
tively (3). There is a trend nowadays to divide OLP into 
three categories, being 1) reticular/popular/plaque type, 
2) erosive/erythematous type, and 3) ulcerative type (4). 
More than one subtype of OLP may occur in the same 
patient and subtypes may vary in the individual patients 
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during the course of the disease. As in CLP, there is 
usually a bilateral and symmetrical distribution. Reticu-
lar OLP, which is probably the most common presenta-
tion, is usually asymptomatic while the other types may 
cause pain or discomfort, either spontaneously or dur-
ing meals, e.g. during the use of spicy food. The clinical 
course of OLP is characterized by remissions and exac-
erbations. At present, there is no effective treatment for 
OLP (5). Therefore, treatment can only be symptomatic 
and usually consists of topical application of corticos-
teroids either as an ointment or a mouth rinse.
In the past decades, several disease scoring systems 
(DSSs) for OLP have been reported. The aim of the 
present study is to critically review these scoring systems.
Material and Methods
A Pubmed and Google Scholar search has been per-
formed using the keywords “(oral) lichen planus”, “scor-
ing system”, and “classification” to retrieve publications 
on Disease Scoring Systems for oral lichen planus in the 
English literature since 1980. 
Results
As a result of the search a  total number of 22 publica-
tions have been collected. A brief summary of the vari-
ous parameters that have been used in the various DSSs 
is depicted in table 1 and table 1 Continued. It is obvious 
that there is a wide variety in the objective and symp-
tomatic parameters that have been used in the various 
Author(s) Objective morphological findings Subjective findings (symptoms) 
Sloberg et al, 1983(6)          Scale:                                                                     
cured 
improved 
unchanged 
mixed 
Scale: 
cured 
improved 
unchanged 
mixed 
Giustina, 1986(7)                 Scale from 0-5: 
0= no clinical disease 
5= severe clinical disease including ulceration 
No scale 
Eisen et al, 1990(8)              Scale from 0-3: 
0= no clinical disease  
3= severe clinical disease 
Global index: 
0= worse or no change (≤ 20%) 
1= moderate improvement (20%-50%) 
2= remarkable improvement (50%-80%) 
3= (almost) complete improvement (80%-
100%) 
Scale from 0-3: 
0= no disease 
3= severe disease 
Holmstrup et al, 1990(9) Four categories for gingival lichen planus: 
improvement 
marked improvement 
aggrevation 
marked aggrevation 
Bleeding when toothbrushing 
Pain or tenderness when eating or toothbrushing 
Silverman et al, 1991(10)    No scale VAS for pain 
1= 25% 
4= 100% 
Thongprasom et al, 
1992(11)                               
Scale from 0-3: 
0= no lesion 
1= mild white striae, no erythema 
2= white striae with atrophic area (≤ 1cm2  
Scale from 0-1: 
0= not cured 
1= cured: no erythema, no white striae or other 
symptoms 
Bagán-Sebastián et al, 
1992(12)                               
Scale from 0-3: 
1= 1 oral site involved 
2= 2 oral sites involved 
3= 3 or more oral sites involved 
No scale 
Harpenau et al, 1995(13)     Lesions scored by area of involvement by 
ulceration, erythema, and reticulations using an 
intraoral grid system 
No scale 
Ramón-Fluixá et al, 
1999(14) 
Two clinical subtypes 
1=.white lesions only (reticular, papular, 
plaque-form) 
2=atrophic-erosive 
Affecting or not affecting other mucosal 
surfaces than gingiva 
Extent of the disease 
grade 1 ≤25% 
grade 2 25-75% 
grade 3 ≥ 75% 
No scale 
Chainani-Wu et al, 
2001(15)]                             
Scale for clinical signs from 0-3: 
0= no clinical signs of the disease 
1= reticular 
2=atrophic 
3=erosive 
Severity score= signs+symptom score 
Symptom score from 0-3: 
0= no symptoms 
1= mild symptoms, not affecting quality of life 
(QOL) 
2= moderate symptoms, affecting QOL 
3= severe symptoms,significant affecting QOL 
Rozycki et al, 2002(16)       NR= no response 
PR= partial response defined as substantial 
decrease in size of the lesions reported by the 
clinician or the patient via a telephone 
questionnaire 
CR= complete response defined as a total 
resolution 
No scale 
Kaliakatsou et al, 
2002(17)                               
0= no lesion 
1= white striae only 
2= white striae and erosion ≤ 1 cm2 
3= white striae with erosion ≥ 1 cm2 
4= white striae with ulceration ≤ 1 cm2 
5= white striae with ulceration ≥ 1 cm2 
VAS for pain 
McGill pain questionnaire 
Discomfort ranging from 0-5 (0= no pain; 5= 
unbearable pain) 
Table 1. Reported Disease Scoring Systems for oral lichen planus (4,6-26).
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Hegarty et al, 2002(18)        Measurement of involved mucosal surface VAS for pain 
Pinboonniyom et al, 
2005(4)                                 
Ten oral subsites 
Reticular lesions (0=none; 1= presence of 
white striae) 
Erosive lesions (0= none; 1= lesion  ≤ 1 cm2; 
2= lesions from 1-3 cm2; 3= lesions  ≥ 3 cm2) 
Ulcerative lesions (0= none; 1= lesion  ≤ 1 cm2; 
2= lesions from 1-3 cm2; 3= lesions  ≥ 3 cm2) 
For each of the 3 clinical signs (R,E,U), a score 
was derived by summation of the scores of all 
ten areas 
No scale 
Gorouhi et al, 2007(19)        One marker lesion to assess the clinical activity 
(scale ranging from 0-5) 
VAS for pain 
Oral health profile score 
Escudier et al, 2007(20)       Seventeen oral subsites 
Subsite score (A) 
0= no lesion 
1= evidence of lichen planus 
2= ≥ 50% of buccal mucosa, dorsum of tongue, 
floor of mouth, hard palate, soft palate or 
oropharynx affected 
Severity score (B) 
0= keratosis only 
1= keratosis with mild erythema (≤ 3 mm from 
gingival margin) 
2= marked erythema (e.g. full thickness of 
gingivae, extensive with atrophy or oedema on 
nonkeratinized mucosa) 
3= ulceration present 
The Activity score was calculated as the result 
of multiplying the Subsite score A by the 
Severity score B 
Numerical rating score  
 
 
 
 
 
 
 
 
 
 
 
 
The total score was the result of the 
summation of the Activity score and 
the Pain score 
Malhotra et al, 2008(21)      Five oral subsites 
Areas involved ≤ 50% (1) or ≥ 50% (2) of 
tongue and buccal mucosa; for lips, gingiva and 
palate just uninvolved (0) or involved (1) was 
used 
A total score was obtained by adding the scores 
of all subsites 
Based on the total score a grade was assigned 
(Grade 0= 0 points; grade I= 1-3 points; grade 
II= 4-6 points; grade II= 7-12 points) 
The Severity was expressed as: 
Mild (asymptomatic grade I) 
Moderate (symptomatic grade I or grade II) 
Severe (grade III or erosive lesion of any 
grade)  
No separate score was used 
 
Chainani-Wu et al, 
2008(22)]                              
Sixteen oral subsites 
Erythema score (0= normal, 1= mild erythema, 
2= moderate, 3= severe) 
Ulceration score (0= no ulceration, 1= 0-0.25 
cm2, 2=0.25-1 cm2, 3= 1cm2 or greater) 
VAS for pain 
Numerical rating score 
Change in symptoms scale 
Modified oral mucositis index 
Radfar et al, 2008(23) Lesions measured on longest dimension VAS for pain 
Wu et al, 2010(24)               Seize of erosive area 
Recurrence rate 
Adverse effects of treatment 
VAS for pain 
Park et al, 2012(25)              The system described by Pinboonniyom et al., 
2005[4] plus pain score                                  
Numerical rating score  
 
Kaplan et al, 2012(26) Clinical severity defined as the number of oral 
locations involved (buccal, tongue, floor, 
gingiva) 
Patients'verbal description of their 
oral condition into 4 categories: 
complete remission 
partial remission 
no change 
exacerbation 
 
Table 1 Continued. Reported Disease Scoring Systems for oral lichen planus (4,6-26).
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DSSs, ranging from just the use of a VAS score in the 
study from Silverman et al. (10)  to a rather detailed 
system in the studies from Pinboonniyom et al. (4) and 
Escudier et al. (20).  
Discussion and Conclusions
The number of collected publications on DSSs for OLP 
is actually higher than twenty-two, since a number of 
scoring systems have been used in studies on the symp-
tomatic treatment of OLP that did not focus on the dis-
ease scoring system, as is shown in a review in 2011 of 
treatment interventions (27). Nevertheless, the publica-
tions, as being listed in table 1, are representative of the 
various types of DSSs. Almost all of the reported DSSs 
are based on the extent of the disease, i.e. the number 
of affected oral subsites, the size of the lesions and the 
clinical presentation, such as reticular, erosive/ery-
thematous or ulcerative with or without the use of scor-
ing system for symptoms.  In the various DSSs there are 
differences in the use of the terms activity, severity and 
extent of the disease. In some DSSs the erosive type of 
OLP is graded as a more severe type of OLP than the 
reticular type, while in such studies also a pain score 
has been applied. In yet other DSSs the extent of the 
disease is used as a parameter for the severity or the 
activity of OLP. 
Remarkably, there is only one study in which two of the 
reported DSSs have been compared for their applicabil-
ity (28); not surprisingly, the authors of that study rec-
ommended to design a uniform scoring system. Indeed, 
due to the diversity of both the objective and subjective 
parameters that have been used in the various DSSs it 
impossible to compare the results obtained from differ-
ent studies on the treatment of oral lichen planus.
Because of its natural course of remissions and exacer-
bations, sometimes lifelong, and also due to the varying 
distribution pattern and the varying clinical types, e.g. 
reticular and erosive (Figs. 1 and 2), the use of a DSS 
for the assessment of treatment results in OLP is rather 
questionable.
Fig. 1. Plaque-type lichen planus on the borders of the tongue; mild symptoms (a,b); same patients after two months; symptoms unchanged 
as reported by the patient (c,d). How to incorporate the morphological changes in a disease scoring system? A quality of life scoring sys-
tem may be more useful.
A B
C D
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Silverman did not use objective, morphological param-
eters in his study but merely used a visual analog scale 
scale (VAS) for pain (10). With regard to gingival OLP 
one may question whether pain alone is a proper param-
eter. Patients with erosive OLP of the gingiva may not so 
much complain of pain but rather of bleeding on tooth-
brushing; in some of these patients the main complaint 
may even be an aesthetic one. In this respect, one may 
consider to develop a symptomatic scoring system for 
patients with OLP of the gingiva only. Yet other patients 
with OLP only report pain or discomfort when eating 
spicy food. Therefore, as has been mentioned already by 
several authors (15,19), the use of a quality of life scor-
ing system (29), adjusted for use in OLP patients, may 
be considered, perhaps even as the only parameter for 
the assessment of treatment results. 
In conclusion, the presently available disease scoring 
systems for oral lichen planus may all have some merit, 
particularly for research purposes. Because of the di-
versity of these systems and the lack of acceptance of 
one of these systems for uniform use, there is a need 
for an international, authorized consensus meeting on 
this subject. One actually may consider to only design 
a quality of life scoring system adapted for use in OLP 
patients.
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